PedAM
Pediatric Disease Annotations & Medicines
| Disease | lymphoma |
| Phenotype | C0019163|hepatitis b |
| Sentences | 20 |
| PubMedID- 23775967 | Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis b virus reactivation in patients with lymphoma and resolved hepatitis b. |
| PubMedID- 25848698 | We performed a retrospective study to analyse the characteristics and clinical outcomes of diffuse large b-cell lymphoma (dlbcl) patients with hepatitis b virus (hbv) infection and compare with those without hbv infection. |
| PubMedID- 25803356 | Treatment to prevent hepatitis b virus reactivation in patients with lymphoma receiving chemotherapy--reply. |
| PubMedID- 24157019 | Background: acute-on-chronic liver failure (aoclf) occurs in lymphoma patients because of hepatitis b virus (hbv) reactivation. |
| PubMedID- 23601025 | Reactivation of hepatitis b virus in a patient with adult t-cell leukemia-lymphoma receiving the anti-cc chemokine receptor 4 antibody mogamulizumab. |
| PubMedID- 24367885 | hepatitis b reactivation in patient with non-hodgkin's lymphoma receiving rituximab-based chemotherapy: need for education and attention. |
| PubMedID- 26058465 | This study aimed to assess hbv reactivation and hepatitis occurrence in diffuse large b-cell lymphoma (dlbcl) patients with resolved hepatitis b receiving rituximab-containing chemotherapy compared with hbsag-negative/hbcab-negative patients to identify risk factors for hbv reactivation and hepatitis occurrence and to analyze whether hbv reactivation and hepatitis affect the survival of dlbcl patients with resolved hepatitis b. |
| PubMedID- 24516927 | [consensus on the management of lymphoma in patients with hepatitis b virus infection]. |
| PubMedID- 25803354 | Treatment to prevent hepatitis b virus reactivation in patients with lymphoma receiving chemotherapy. |
| PubMedID- 24778676 | [16] the pathogenesis of pel-like lymphoma in patients with hepatitis b-related cirrhosis is still unknown. |
| PubMedID- 23606919 | [12] reported that entecavir is more effective than lamivudine in preventing hepatitis b reactivation in patients with lymphoma under chemotherapy. |
| PubMedID- 25947024 | Here we report this rare case of hepatic malt lymphoma in a patient with chronic hepatitis b, and present a review of the literature. |
| PubMedID- 24851363 | [risk of reactivation of hepatitis b in patients with the lymphoma hbsag negative , anti-hbc positive treated with rituximab-chop]. |
| PubMedID- 25030854 | Primary hepatic mucosa-associated lymphoid tissue lymphoma and hemangioma with chronic hepatitis b virus infection as an underlying condition. |
| PubMedID- 23529561 | Primary hepatic lymphoma in a patient with chronic hepatitis b and c infection: diagnostic pitfalls and therapeutic challenge. |
| PubMedID- 25248874 | Risk and prophylaxis strategy of hepatitis b virus reactivation in patients with lymphoma undergoing chemotherapy with or without rituximab. |
| PubMedID- 21452121 | [viral hepatitis b in a patient with follicular lymphoma treated with biological therapy]. |
| PubMedID- 21696249 | We describe a case of severe acute hepatitis b developing in a patient with hodgkin's lymphoma after chemotherapy and before radiotherapy. |
| PubMedID- 22432084 | The association of hepatitis b virus infection with b-cell non-hodgkin lymphoma - a review. |
| PubMedID- 26481866 | Hepatosplenic t-cell lymphoma with coexistent hepatitis b infection: a rare clinicopathologic entity. |
Page: 1